Top Markets
Coin of the day
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc.

OPNT
株式のランク #22841
Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical... Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical enterprise, primarily focused on inventing remedies for both various addictions and drug overdoses. A key product in their current portfolio is NARCAN nasal spray, which provides a critical solution for counteracting opioid overdoses. Their development pipeline is robust, featuring several promising drug candidates designed to address further opioid overdose reversal needs, alcohol use disorders, acute cannabinoid overdose, and opioid use disorders. The company, which established itself in 2005, was initially named Lightlake Therapeutics Inc. before rebranding as Opiant Pharmaceuticals, Inc. in January 2016. Its corporate headquarters are located in Santa Monica, California.
株価
$20.65
最終同期: 2023-03-01
時価総額
$82.52M
変化(1日)
-0.58%
変化(1年)
0.00%
US
取引 Opiant Pharmaceuticals, Inc. (OPNT)

カテゴリー

Opiant Pharmaceuticals, Inc.(OPNT)の利益
2026 時点の利益 TTM: 0
Opiant Pharmaceuticals, Inc. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Opiant Pharmaceuticals, Inc. の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差
$5.27B -
US
$1.95B -
NL
$-3.09B -
US
$-4.02B -
AU
- -
CH